vs
Arteris, Inc.（AIP）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Arteris, Inc.的1.8倍（$35.5M vs $20.1M），Arteris, Inc.净利率更高（-42.2% vs -304.2%，领先262.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 30.0%），Arteris, Inc.自由现金流更多（$3.0M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 24.7%）
Arteris公司是一家跨国科技企业，总部位于美国加利福尼亚州坎贝尔，主营片上网络（NoC）知识产权以及系统芯片（SoC）集成自动化软件的研发，产品用于各类半导体芯片与芯粒设计，客户覆盖汽车电子、人工智能、机器学习、企业计算、通信、消费电子、工业以及航空航天国防等多个领域。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
AIP vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.1M | $35.5M |
| 净利润 | $-8.5M | $-108.1M |
| 毛利率 | 90.8% | 59.8% |
| 营业利润率 | -42.0% | -304.8% |
| 净利率 | -42.2% | -304.2% |
| 营收同比 | 30.0% | 681.7% |
| 净利润同比 | -3.7% | 39.6% |
| 每股收益（稀释后） | $-0.19 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $20.1M | $35.5M | ||
| Q3 25 | $17.4M | $5.2M | ||
| Q2 25 | $16.5M | $19.2M | ||
| Q1 25 | $16.5M | $14.7M | ||
| Q4 24 | $15.5M | $4.5M | ||
| Q3 24 | $14.7M | $26.1M | ||
| Q2 24 | $14.6M | $14.4M | ||
| Q1 24 | $12.9M | $13.8M |
| Q4 25 | $-8.5M | $-108.1M | ||
| Q3 25 | $-9.0M | $-162.3M | ||
| Q2 25 | $-9.1M | $-171.9M | ||
| Q1 25 | $-8.1M | $-202.5M | ||
| Q4 24 | $-8.2M | $-178.9M | ||
| Q3 24 | $-7.7M | $-95.8M | ||
| Q2 24 | $-8.3M | $-97.5M | ||
| Q1 24 | $-9.4M | $-91.4M |
| Q4 25 | 90.8% | 59.8% | ||
| Q3 25 | 89.9% | -183.8% | ||
| Q2 25 | 89.4% | -4.9% | ||
| Q1 25 | 90.8% | -48.0% | ||
| Q4 24 | 89.8% | -181.4% | ||
| Q3 24 | 90.1% | 53.7% | ||
| Q2 24 | 90.0% | 36.2% | ||
| Q1 24 | 88.7% | 19.1% |
| Q4 25 | -42.0% | -304.8% | ||
| Q3 25 | -50.1% | -3327.6% | ||
| Q2 25 | -50.0% | -916.8% | ||
| Q1 25 | -46.6% | -1297.9% | ||
| Q4 24 | -45.9% | -4042.4% | ||
| Q3 24 | -53.8% | -377.1% | ||
| Q2 24 | -51.1% | -697.4% | ||
| Q1 24 | -70.5% | -698.4% |
| Q4 25 | -42.2% | -304.2% | ||
| Q3 25 | -51.6% | -3135.3% | ||
| Q2 25 | -55.3% | -894.2% | ||
| Q1 25 | -49.1% | -1373.3% | ||
| Q4 24 | -53.0% | -3935.5% | ||
| Q3 24 | -52.2% | -367.5% | ||
| Q2 24 | -57.2% | -676.6% | ||
| Q1 24 | -72.6% | -662.4% |
| Q4 25 | $-0.19 | $-0.17 | ||
| Q3 25 | $-0.21 | $-0.36 | ||
| Q2 25 | $-0.22 | $-0.41 | ||
| Q1 25 | $-0.20 | $-0.50 | ||
| Q4 24 | $-0.19 | $-0.56 | ||
| Q3 24 | $-0.20 | $-0.34 | ||
| Q2 24 | $-0.22 | $-0.40 | ||
| Q1 24 | $-0.25 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.9M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $-14.6M | $1.1B |
| 总资产 | $115.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $33.9M | $743.3M | ||
| Q3 25 | $39.0M | $659.8M | ||
| Q2 25 | $38.0M | $525.1M | ||
| Q1 25 | $42.3M | $500.5M | ||
| Q4 24 | $43.8M | $594.4M | ||
| Q3 24 | $48.7M | $427.6M | ||
| Q2 24 | $45.8M | $474.3M | ||
| Q1 24 | $44.8M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $-14.6M | $1.1B | ||
| Q3 25 | $-11.4M | $1.0B | ||
| Q2 25 | $-7.5M | $919.1M | ||
| Q1 25 | $-4.8M | $933.9M | ||
| Q4 24 | $-1.2M | $1.0B | ||
| Q3 24 | $2.2M | $524.6M | ||
| Q2 24 | $5.3M | $584.4M | ||
| Q1 24 | $9.5M | $401.2M |
| Q4 25 | $115.0M | $1.5B | ||
| Q3 25 | $107.7M | $1.4B | ||
| Q2 25 | $106.9M | $1.3B | ||
| Q1 25 | $98.3M | $1.3B | ||
| Q4 24 | $106.1M | $1.4B | ||
| Q3 24 | $97.7M | $726.5M | ||
| Q2 24 | $96.4M | $775.9M | ||
| Q1 24 | $101.4M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $3.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | 15.1% | -133.1% |
| 资本支出强度资本支出/营收 | 0.7% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.3M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $3.2M | $-46.1M | ||
| Q3 25 | $3.2M | $-117.4M | ||
| Q2 25 | $-2.5M | $-76.4M | ||
| Q1 25 | $2.9M | $-132.0M | ||
| Q4 24 | $-2.6M | $-115.4M | ||
| Q3 24 | $1.1M | $-59.2M | ||
| Q2 24 | $311.0K | $-82.2M | ||
| Q1 24 | $477.0K | $-102.3M |
| Q4 25 | $3.0M | $-47.3M | ||
| Q3 25 | $2.5M | $-117.6M | ||
| Q2 25 | $-2.8M | $-79.6M | ||
| Q1 25 | $2.7M | $-133.8M | ||
| Q4 24 | $-2.7M | $-116.7M | ||
| Q3 24 | $1.1M | $-63.8M | ||
| Q2 24 | $264.0K | $-83.4M | ||
| Q1 24 | $281.0K | $-109.0M |
| Q4 25 | 15.1% | -133.1% | ||
| Q3 25 | 14.2% | -2272.5% | ||
| Q2 25 | -17.2% | -413.9% | ||
| Q1 25 | 16.2% | -907.4% | ||
| Q4 24 | -17.3% | -2567.7% | ||
| Q3 24 | 7.4% | -244.6% | ||
| Q2 24 | 1.8% | -578.5% | ||
| Q1 24 | 2.2% | -789.9% |
| Q4 25 | 0.7% | 3.5% | ||
| Q3 25 | 4.1% | 4.7% | ||
| Q2 25 | 2.2% | 16.4% | ||
| Q1 25 | 1.1% | 12.4% | ||
| Q4 24 | 0.3% | 28.6% | ||
| Q3 24 | 0.2% | 17.5% | ||
| Q2 24 | 0.3% | 8.2% | ||
| Q1 24 | 1.5% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AIP
| License And Maintenance | $17.5M | 87% |
| Variable Royalties And Other | $2.6M | 13% |
RXRX
暂无分部数据
